TPST251017P00000500 Option on Tempest Therapeutics

An 'Out of The Money' option on Tempest has a strike price that Tempest Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Tempest Therapeutics' 'Out of The Money' options include buying the options if you expect a big move in Tempest Therapeutics' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

Tempest Therapeutics' Option Greeks for the contract ending on 2025-10-17 at a strike price of 0.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Tempest Therapeutics' option greeks, its implied volatility helps estimate the risk of Tempest Therapeutics stock implied by the prices of the options on Tempest Therapeutics' stock.

Put options written on Tempest Therapeutics grant holders of the option the right to sell a specified amount of Tempest Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Tempest Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Tempest Therapeutics is like buying insurance aginst Tempest Therapeutics' downside shift.

By selling Tempest Therapeutics' put option, the investors signal their bearish sentiment. A short position in a put option written on Tempest Therapeutics will generally make money when the underlying price is above the strike price. Therefore Tempest Therapeutics' put payoff at expiration depends on where the Tempest Stock price is relative to the put option strike price. The breakeven price of 0.12 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Tempest Therapeutics' price. Finally, at the strike price of 0.5, the payoff chart is constant and positive.

Tempest Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Tempest. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Tempest. It also shows strike prices and maturity days for a Tempest Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.